The State Board of Pharmacy announced a virtual Stakeholder Meeting on June 14th to receive feedback on Notice, Draft Rules, SB21-011, SB21-094, SB21-122, and SB21-123.
- Potential rule changes related to Colorado Senate Bill 21-011 (Concerning responsibilities of a pharmacist related to opiate antagonists);
- Potential rule changes related to Colorado Senate Bill 21-094 (Concerning implementing recommendations contained in the 2020 sunset report that make changes regarding the practice of professions regulated by the Board);
- Implementing Colorado Senate Bill 21-122 (Concerning the bulk purchase of opiate antagonists according to a standing order);
- Implementing Colorado Senate Bill 21-123 (Concerning expanding the Canadian prescription drug importation program); and
- New and revised rules are recommended by the Board and stakeholders to provide clarity and a general cleanup of the rules.
To register in advance, go to Webinar Registration. Written comments should be sent by June 10th to – dora_dpo_rulemaking@state.co.us.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.